Business Context and Reporting Period
Company: Supernus Pharmaceuticals, Inc. (SUPN)
Filing Type: Form 8-K (Current Report)
Date of Report: July 22, 2026
Subject: Announcement of the timing for the Second Quarter 2026 financial results.
Key Financial Metrics
This filing is a procedural announcement regarding the release of future financial data. It does not contain specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity for the second quarter of 2026 or any prior period. The filing text does not provide a clear value for these items.
Material Changes
No material changes to financial condition or operations are reported in this document. The filing solely notifies investors of the scheduled date for the upcoming earnings release.
Guidance, Outlook, and Management Commentary
- Earnings Release Date: The company will report second quarter 2026 results after market close on Tuesday, August 4, 2026.
- Conference Call: A conference call and webcast are scheduled for Tuesday, August 4, 2026, at 4:30 p.m. E.T.
- Exhibits: A press release dated July 22, 2026, is included as Exhibit 99.1.
Investor Verification Checklist
- Verify the actual financial results when released on August 4, 2026.
- Review the press release (Exhibit 99.1) for any additional context not included in the 8-K summary.
- Attend or listen to the conference call on August 4, 2026, for management commentary on Q2 2026 performance.